Pulling SEC filings + quote and writing the call…

UNITED STATES LIME & MINERALS INC
Next earnings Jul 28, 2026 · consensus $1.33 EPS, $110M rev
Last earnings -1.1% on 2026-04-29
Debt-free lime monopoly compounding earnings ~23%/yr at expanding margins — quality you rarely buy at a 21.8x P/E.
Revenue (FY2025) $373M · FY2025
Quality fundamentals and an attractive price line up (~65% below fair value) — the rarer case where both the business and the entry look good.
USLM is a textbook high-quality compounder hiding in a boring SIC code. Revenue has nearly doubled in four years ($189M FY2021 → $373M FY2025) while net income more than tripled ($37M → $134M), and FY2025 kept the streak going: revenue +17.3%, net income +23.4%, diluted EPS +23.2%. Critically, this isn't volume-only growth — gross margin sits at 48.9%, operating margin at 42.4% and net margin at 36.0%, with every profit line growing faster than revenue (gross +26.7%, operating +26.4%). That margin expansion reflects the pricing power of a regional lime producer: lime is heavy, low-value-per-ton and uneconomic to ship far, so each plant enjoys a natural geographic moat across construction, environmental (flue-gas/water treatment), metals and ag end-markets.
The balance sheet is pristine to the point of being a fortress: zero long-term debt, total liabilities of just $50.3M against $631M of equity (0.08x), and $371M of cash (up 33.5%) — roughly $12.9/share, or ~13% of the market cap. ROE of 21.3% is achieved with essentially no leverage, which means returns on operating capital are far higher still. Operating cash flow of $165M (+30.9%) comfortably funds the sharply elevated $62.7M capex (+128.7%), still leaving ~$100M of free cash flow that backstops the growing dividend ($6.87M, +20.2%) and buybacks. The capex surge is the key tell: management is plowing cash into the modernization/expansion projects the MD&A repeatedly references, planting the seeds for the next leg of capacity-driven growth.
Is USLM a buy? The one-page verdict, explained →
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $189M | $236M | $281M | $318M | $373M |
| Gross profit | $59.3M | $70.3M | $103M | $144M | $182M |
| Operating income | $46.4M | $54.8M | $85.4M | $125M | $158M |
| Net income | $37.0M | $45.4M | $74.5M | $109M | $134M |
| Diluted EPS | $6.54 | $1.60 | $2.61 | $3.79 | $4.67 |
| Net margin | 19.6% | 19.2% | 26.5% | 34.3% | 36.0% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Annual meeting vote results: directors elected, routine proposals ratified
Q1 2026 10-Q; debt-free, $371M+ cash, growth momentum intact
Q1 2026 earnings release furnished; growth streak continuing off record FY2025
Proxy for 2026 annual meeting: board slate and comp; no major changes
FY2025 10-K: rev $373M, NI $134M, zero LT debt, 49% gross margin, record
FY2025 results: revenue $373M +17%, net income $134M +23%, record year
Q3 2025 10-Q; revenue and earnings growth sustained, no debt
Q3 2025 earnings release furnished; revenue and margins still expanding
Q2 2025 10-Q; pricing power lifting margins, strong cash build
Sources: SEC EDGAR (CIK 0000082020, latest 10-Q filed 2026-04-30) · EODHD · Proprietary analysis · as of 6/29/2026, 10:45:40 PM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 29, 2026, 6:45 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
| 2026-05-01 | Hawkins Tom S Jr Director | Award | 1.27K @ $110.00 | $140K |
| 2026-05-01 | Wolkenstein Jon A Director | Award | 1.27K @ $110.00 | $140K |
| 2026-05-01 | Weirich Lila R Director | Award | 1.27K @ $110.00 | $140K |
| 2026-05-01 | Duhe Sandra C Director | Award | 1.27K @ $110.00 | $140K |
| 2026-05-01 | CARDIN RICHARD W Director | Award | 1.27K @ $110.00 | $140K |
| 2026-03-17 | DOUMET ANTOINE M Director | Exercise | 12.0K @ $10.71 | $129K |
| 2026-03-03 | Duhe Sandra C Director | Sell | 1.28K @ $120.45 | $154K |
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1195 tracked peers · median